Patent Law Weblog
recent posts
- Apple v. Squires: USPTO Director Has Unlimited Discretion on IPR Institution
- The Ghost in the Machine: Why GenAI Can Be Both a Brilliant Researcher and a Terrible Advocate
- Bayer Files Suit Against Trio of COVID-19 Vaccine Makers
- Allen v. Cooper (4th Cir. 2026)
- To Require an Inventor ID, or Not to Require an Inventor ID – That Is the Question
about
Month: August 2007
-
Noonan: David Boundy at Cantor Fitzgerald alerted us here at Patent Docs about the provisions of M.P.E.P. § 710.06 (see "Procuring Patent Prosecution from the Present PTO"). Mr. Boundy shares some additional points with Patent Docs readers. By David Boundy — MPEP § 710.06 requires a showing of "error," not just disagreement. MPEP…
-
By Christopher P. Singer — As reported by Patent Docs and others, the USPTO will publish the new rules relating to claims and continuations in the Federal Register on August 21, 2007. On Thursday, August 23, 2007, at 1:00 p.m. Eastern/10:00 a.m. Pacific, the USPTO will hold a special webcast to discuss various…
-
By Kevin E. Noonan — The U.S. Patent and Trademark Office today announced, by press release, the broad contours of its long-anticipated new rules regarding continuation applications. The rules themselves will be published tomorrow in the Federal Register, pursuant to the requirements of the Administrative Procedures Act. According to the press release (and…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Novartis Pharmaceuticals Corporation et al. v. Ranbaxy Inc. et al.3:07-cv-03755; filed August 9, 2007 in the District of Court of New Jersey…
-
By Kevin E. Noonan — There have been two distinct stages in the developing world’s reaction to the patent-related provisions of the General Agreement on Tariffs and Trade (GATT) and the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) that established the World Trade Organization (WTO). The first is illustrated by Article…
-
August 23-24, 2007 – Current Issues in Complex IP Licensing: Business and Legal Factors for Licensing Transactions (Law Seminars International) – Seattle, WA August 24, 2007 – Managing Patent Prosecution and Litigation: New Regulations, Rules and Challenges, along with Practical Tips for Success (Law Seminars International) – San Francisco, CA September 6-7, 2007 – Emerging…
-
By Jason Derry — Invitrogen Corp. has announced that it will partner with IDEXX Laboratories, Inc. to distribute and develop new water testing products. Under the collaboration, IDEXX will distribute and market water testing kits that incorporate Invitrogen’s technologies for detecting various microorganisms. The agreement enables Invitrogen, which recently started selling a Cryptosporidium…
-
American Conference Institute (ACI) will be holding a conference on Pharma and Biotech Collaborative Agreements on November 13-14, 2007 in New York, NY. The conference will provide information about safeguarding intellectual property rights, minimizing risks through effective due diligence, developing effective governance processes, drafting termination provisions, anticipating the impact of generics, and avoiding pitfalls associated…
-
Patent Resources Group (PRG) will be offering a course entitled "Biotechnology: Patent Prosecution, Licensing, Litigation & Hatch-Waxman" on October 25-27, 2007 in Palm Springs, CA. The course will focus on: Biotechnology patent prosecution; Biotechnology patent enforcement; The Hatch-Waxman effect on biotechnology patent practice; and Licensing biotechnology inventions. A syllabus for the course can be found…
-
By Donald Zuhn — On Tuesday, ARIUS Research Inc. announced that it had been granted U.S. Patent Nos. 7,256,271 and 7,256,272. According to the statement released by ARIUS, the ‘271 patent relates to a CEA targeting antibody having demonstrated potent anti-tumour activity in colon and breast cancer models, and the ‘272 patent relates…
Patent Docs 